Market Cap (In SEK)
67.74 Million
Revenue (In SEK)
-
Net Income (In SEK)
-17.89 Million
Avg. Volume
25.1 Thousand
- Currency
- SEK
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.884-2.89
- PE
- -
- EPS
- -
- Beta Value
- 0.629
- ISIN
- SE0015987904
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Dr. John Öhd M.D., Ph.D.
- Employee Count
- -
- Website
- https://www.modustx.com
- Ipo Date
- 2021-07-22
- Details
- Modus Therapeutics Holding AB (publ), a biotechnology company, develops a treatment for sepsis and septic shock in Sweden. Its lead product is Sevuparin, a polysaccharide to treat patients with sepsis and septic shock, which is under Phase Ib clinical study. The company was founded in 2011 and is headquartered in Stockholm, Sweden.
More Stocks
-
DGII
-
SBHGFSBI Holdings, Inc.
SBHGF
-
6170Welldone Company
6170
-
SBGI
-
2906Collins Co., Ltd.
2906
-
688037KINGSEMI Co., Ltd.
688037
-
6888Acmos Inc.
6888
-
EDUCOMPEducomp Solutions Limited
EDUCOMP